# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001485003-22-000154
Filing Date
2022-11-07
Accepted
2022-11-07 08:00:30
Documents
10
Period of Report
2022-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | sesnform3q2022earningsrele.htm | 8-K | 27198
2 | EX-99.1 | ex991_3q2022earningsrele.htm | EX-99.1 | 31716
3 |  | ex991_3q2022earningsrele001.jpg | GRAPHIC | 239851
4 |  | ex991_3q2022earningsrele002.jpg | GRAPHIC | 284016
5 |  | ex991_3q2022earningsrele003.jpg | GRAPHIC | 308628
6 |  | ex991_3q2022earningsrele004.jpg | GRAPHIC | 335579
7 |  | ex991_3q2022earningsrele005.jpg | GRAPHIC | 337503
8 |  | ex991_3q2022earningsrele006.jpg | GRAPHIC | 224405
9 |  | ex991_3q2022earningsrele007.jpg | GRAPHIC | 150442
10 |  | ex991_3q2022earningsrele008.jpg | GRAPHIC | 143904
| Complete submission text file | 0001485003-22-000154.txt |  | 2849074

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221363775
SIC: 2834 Pharmaceutical Preparations